NextCure Stock Price - NXTC

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NextCure Inc NXTC NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.71 -2.71% 25.46 24.72 27.79 26.02 26.17 00:00:05
Bid Price Ask Price Spread Spread % News
25.50 28.34 2.84 10.02% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,506 725,182 $ 25.78 $ 18,697,656 235,202 13.86 - 109.00
Last Trade Time Type Quantity Stock Price Currency
17:53:52 5 $ 25.46 USD

NextCure Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 700.59M 27.52M 26.87M $ 6.35M $ -4.14M -1.60 -169.25
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 2.40%

more financials information »

NextCure News

Date Time Source News Article
5/29/202008:05GlobeNewswire Inc.NextCure Presents Biomarker Data and Updated Clinical..
5/07/202017:33Edgar (US Regulatory)Quarterly Report (10-q)
5/07/202017:10GlobeNewswire Inc.NextCure Reports First Quarter 2020 Financial Results
5/06/202008:05GlobeNewswire Inc.NextCure to Present at BofA Securities Virtual Health Care..
4/27/202007:49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)
4/27/202006:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)
4/14/202006:04Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NXTC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week32.0033.0924.7228.45619,390-6.54-20.44%
1 Month37.0239.7724.7231.66320,188-11.56-31.23%
3 Months34.2441.8724.7234.05252,457-8.78-25.64%
6 Months52.4370.9824.7243.10262,876-26.97-51.44%
1 Year17.86109.0013.8647.66263,4257.6042.55%
3 Years15.55109.0013.8646.72254,8699.9163.73%
5 Years15.55109.0013.8646.72254,8699.9163.73%

NextCure Description

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. It is focused on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. The company's product candidate, NC318, is an immunomedicine against an immunomodulatory receptor called Siglec-15, or S15.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200606 09:51:34